Author Title Type [ Year(Asc)]
Filters: Author is Wu, Joseph C  [Clear All Filters]
Kernik, D.C., Morotti, S., Wu, H., Garg, P., Duff, H.J., Kurokawa, J., Jalife, J., Wu, J.C., Grandi, E., and Clancy, C.E. (2019). A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources.J Physiol.
Williams, I.M., and Wu, J.C. (2019). Generation of Endothelial Cells From Human Pluripotent Stem Cells.Arterioscler Thromb Vasc Biol39, 1317-1329.
Wang, L., Pegram, M.D., and Wu, J.C. (2019). Induced Pluripotent Stem Cells as a Novel Cancer Vaccine.Expert Opin Biol Ther.
Wu, H., Yang, H., Rhee, J.-W., Zhang, J.Z., Lam, C.Keung, Sallam, K., C Y Chang, A., Ma, N., Lee, J., Zhang, H., et al. (2019). Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.Eur Heart J.
Wu, J.C., Garg, P., Yoshida, Y., Yamanaka, S., Gepstein, L., Hulot, J.-S., Knollmann, B.C., and Schwartz, P.J. (2019). Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.Circ Res125, 653-658.
Abi-Gerges, N., McMahon, C., Vargas, H., Sager, P., Chui, R., Stevens, D., Davila, J., Schaub, J.R., Wu, J.C., Del Rio, C., et al. (2019). The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment.J Pharmacol Toxicol Methods106582.
Pang, L., Sager, P., Yang, X., Shi, H., Sannajust, F., Brock, M., Wu, J.C., Abi-Gerges, N., Lyn-Cook, B., Berridge, B.R., et al. (2019). Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.Circ Res125, 855-867.